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Open access under CC BYThis paper characterizes historical and current tobacco speciﬁc nitrosamine (TSNA) levels in mainstream
(MS) cigarette smoke of US commercial cigarettes. To conduct this analysis, we gathered 35 years of pub-
lished data of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N-nitrosonornicotine (NNN)
levels in MS cigarette smoke. We also assessed internal data of MS smoke NNK and NNN levels generated
from various market monitoring initiatives and from control cigarettes used in a multi-year program for
testing cigarette ingredients. In all, we analyzed machine smoking data from 401 cigarette samples
representing a wide range of products and design characteristics from multiple manufacturers and mar-
ket leaders. There was no indication that TSNA levels systematically increased in cigarette MS smoke over
the 35-year analysis period. In particular, TSNA levels expressed as either per cigarette or normalized for
tar suggest a downward trend in MS smoke over the past 10 years. The apparent downward trend in
TSNA levels in MS smoke may reﬂect industry and agricultural community efforts to reduce levels of
TSNAs in tobacco and cigarette smoke.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction USA Inc. (PM USA), an Altria company. We gathered and analyzedTobacco speciﬁc nitrosamines (TSNAs) are a class of cigarette
smoke constituents believed to play a potential role in smoking re-
lated carcinogenesis (IARC, 2007). The TSNAs, 4-(methylnitrosami-
no)-1-(3-pyridyl)-1-butanone (NNK) and N-nitrosonornicotine
(NNN), have received the greatest attention due to their carcino-
genic activity in animal studies. Both are classiﬁed by the Interna-
tional Agency for Research on Cancer (IARC) as carcinogenic to
humans (Group 1) and both are on the US Food and Drug Admin-
istration established list of harmful and potentially harmful con-
stituents in tobacco products and tobacco smoke (IARC, 2007;
USDHHS, 2012).
Concerns have been raised by the tobacco control community
suggesting that little progress has been made by the tobacco indus-
try to reduce TSNA levels in cigarette smoke (Stepanov et al., 2012).
It has also been suggested that TSNA levels in cigarette smoke may
have even increased over time (Burns et al., 2011a).
This report presents a compilation of mainstream (MS) cigarette
smoke NNK and NNN levels reported in the published literature
and augmented with internal, unpublished data from Philip Morrisitrosamino)-1-(3-pyridyl)-1-
ilip Morris USA Inc.; TSNA,
, Scott.Appleton@altria.com
-NC-ND license.available published and internal data on NNK and NNN levels in
MS cigarette smoke with the following objectives:
1. To characterize historical and current TSNA levels in MS ciga-
rette smoke
2. To conduct secondary analyses to gain insights into patterns of
TSNA levels in MS cigarette smoke over time.
2. Methods
2.1. Published literature values
We gathered published literature values of NNK and NNN levels
in MS cigarette smoke. We searched Chemical Abstracts Service
(CAS) for the CAS Registry number of NNK indexed to ‘‘smoke’’
or ‘‘both’’ (tobacco and smoke). Original research studies that in-
cluded a description of analytical methods identiﬁed in this search
were reviewed to determine if they met the following additional
inclusion criteria:
 NNK and NNN data in MS cigarette smoke because MS smoke is
the most proximate product to which the smoker is exposed to
TSNAs
 TSNA data from cigarettes smoked under Federal Trade Com-
mission (FTC) or International Organization for Standardization
(ISO) conditions, which provide the largest data set available for
evaluation
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with prior analyses of US commercial cigarettes by Hoffmann
and Hoffmann (1997) and Stepanov et al. (2012)
 Peer reviewed published papers
 NNK and NNN levels presented as individual numeric values.
Published studies meeting the above inclusion criteria were in-
cluded in this review.
Numeric values for NNK, NNN, and tar levels are presented as
they appeared in data tables in the original published papers.
The default approach for the year of a given data value was to
use the year of the publication. If a publication speciﬁcally stated
sample acquisition years that differed from the manuscript publi-
cation year, the sample acquisition year stated in the original man-
uscript was used.
2.2. Monitoring data
PM USA afﬁliated and contracted laboratories measured a range
of smoke constituents in commercial cigarettes to help evaluate
new or non-conventional cigarette products. Since 2002, both
NNK and NNN levels in smoke were regularly measured from cig-
arettes produced by PM USA and from competitive US commercial
cigarettes. The constituent analysis methods used were the same
as, or equivalent to, those described in Counts et al. (2005) and
Morton and Laffoon (2008).
2.3. Control cigarette data
PM USA produced control cigarettes as part of a multi-year
ingredient testing program. From 1998 through 2007, PM USA
manufactured control cigarettes to the same speciﬁcations over
60 times and measured the resulting tar, NNN, and NNK levels in
the smoke, among other smoke constituents. The design and con-
struction of control cigarettes were consistent with US commercial
manufacturing, and their speciﬁcations can be found elsewhere
(Gaworski et al., 2011). Although the amount of each component
in the tobacco blend was the same throughout the period of ingre-
dient testing, different crop years were used for the tobaccos due to
depletion of available tobacco inventory. Therefore, in Table 1 we
report the results for PM USA control cigarettes based on the year
of manufacturing, even though the results were ﬁrst published
elsewhere (Coggins et al., 2011a,b,c,d,e,f,g,i).
2.4. Data analyses
The data were analyzed for trend with year by determination of
Pearson’s correlation coefﬁcient, R, using standard statistical anal-
ysis software (IBM SPSS Statistics, Armonk, NY). All data points and
all years were equally weighted. Three time periods were ana-
lyzed: 1978–2012, which is the complete data set; 1978–1995,
which corresponds to Hoffmann and Hoffmann (1997); and
2002–2012, which corresponds to changes in ﬂue-curing practices
and burley seed selection to reduce NNK and NNN in tobacco leaf.3. Results
3.1. TSNA levels in MS smoke: 35 years of data
We identiﬁed 14 published studies that met the data inclusion
criteria (Adams et al., 1987; Brunnemann and Hoffmann, 1991;
Brunnemann et al., 1996; Counts et al., 2005, 2006; Djordjevic
et al., 1991; Hecht et al., 1979; Hoffmann et al., 1979, 1982,
1994; Patskan et al., 2008; Roemer et al., 2004; Stepanov et al.,
2012; Swauger et al., 2002). Table 1 presents cigarette productidentiﬁcations, levels of MS smoke tar (mg/cigarette), NNK (ng/cig-
arette), and NNN (ng/cigarette), and sources of the data presented
in this review. The data in Table 1 are presented in chronological
order according to either the year of the publication or, when
reported, the year of sample acquisition (see Section 2). Because
several papers reported sample acquisition years that were differ-
ent from publication years, the publication years presented in
Table 1 are not necessarily presented in strict chronological order.
We were able to acquire data from a total of 401 cigarette samples
analyzed for MS smoke NNK and NNN levels over a 35-year period.
This includes data from published studies and internal data gener-
ated from PM USA-afﬁliated and contracted laboratories. Collec-
tively, these data reﬂect a wide range of US commercial cigarette
products from multiple manufacturers and include a wide range
of design characteristics and market leaders.
Studies published prior to the 1990s were conducted primarily
by scientists from the American Health Foundation, who typically
analyzed small numbers of samples. Studies conducted from the
mid-1990s to the present were primarily market-map studies
conducted by the cigarette industry, which tended to analyze lar-
ger numbers of samples.
Fig. 1 presents a scatter plot of 35 years of data as the sum of
NNK plus NNN expressed as ng/cigarette. Note higher and more
variable levels in early years with a ﬂattening of levels in later
years.
TSNA levels in MS cigarette smoke can be inﬂuenced by several
variables. The most prominent are the TSNA levels of the cigarette
tobacco blend and the overall smoke yield of the cigarette. Because
overall smoke yields can markedly inﬂuence TSNA levels in MS
smoke of cigarettes with similar blends, it is possible that temporal
trends in cigarette tar levels or sample selections could bias an
assessment of TSNA levels in MS cigarette smoke over time. To cor-
rect for the effect of overall smoke yields, we normalized smoke
TSNA data by dividing the levels of TSNAs by the amount of tar
per cigarette. A scatter plot of these data as the sum of NNK plus
NNN expressed as ng/mg tar is presented in Fig. 2.
For the entire data set 1978–2012 (NNK + NNN)/tar trended
down with year (R = 0.62) and the trend was statistically signiﬁ-
cant (p < 0.00001). Comparable analyses for NNK + NNN on a per
cigarette basis for the time period 1978–2012 showed similar re-
sults (R = 0.54, p < 0.00001). Removal from the 1978–2012 data
set of Virginia blended cigarettes, which are known to have gener-
ally lower NNK and NNN, did not signiﬁcantly alter the results on
either (NNK + NNN)/tar (R = 0.59, p < 0.00001) or NNK + NNN per
cigarette (R = 0.52, p < 0.00001).
3.2. Have TSNA levels increased over time?
Several papers published by Hoffmann and Hoffmann (1994,
1997) and Hoffmann et al. (1993) suggest that NNK levels in MS
cigarette smoke have increased over time, speciﬁcally from
1979–1995. In all of these papers, the data that are presented ap-
pear to be from the same line graph and data from a single uniden-
tiﬁed brand of cigarette referred to as ‘‘US leading NF cigarette.’’
These sources are frequently cited by other researchers to support
the suggestion that TSNA levels have generally increased in ciga-
rette smoke over unspeciﬁed periods of time (Burns et al.,
2011a,b). The reports in which Hoffmann suggests that TSNAs have
increased over time are review articles where data are presented in
the form of line graphs, but the original sources of the data in the
graphs are not presented. Moreover, we were unable to identify a
primary original source for these data. However, Hoffmann and
others published a signiﬁcant amount of data regarding cigarette
smoke TSNA during 1978–1995.
We therefore, conducted a secondary analysis of data from pub-
lished sources from the period of 1978–1995 to characterize NNK
Table 1
Machine smoking data from 401 cigarette samples representing a wide range of products and design characteristics from multiple manufacturers and market leaders.
Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Commercial w/o ﬁlter NR 110 240 Hoffmann et al. (1979)
Commercial with ﬁlter NR 150 310 Hoffmann et al. (1979)
Commercial NF NR 110 240 Hecht et al. (1979)
Commercial F NR 190 310 Hecht et al. (1979)
Commercial D F 12.9 213 342 Hoffmann et al. (1982)
Commercial E F 13.4 249 513 Hoffmann et al. (1982)
Commercial B F 14.2 252 324 Hoffmann et al. (1982)
Commercial A F 13 360 458 Hoffmann et al. (1982)
Commercial C F 13.6 399 505 Hoffmann et al. (1982)
Commercial B NF 22.7 481 533 Hoffmann et al. (1982)
Commercial A NF 21.8 720 816 Hoffmann et al. (1982)
Commercial C NF 22.5 727 813 Hoffmann et al. (1982)
Commercial D NF 23.3 803 1110 Hoffmann et al. (1982)
Commercial E NF 21.8 868 1760 Hoffmann et al. (1982)
Commercial D (PF) 0.9 17.3 66.3 Adams et al. (1987)
Commercial C (F) 6.8 56.2 273 Adams et al. (1987)
Commercial B (F) 15.6 180 488 Adams et al. (1987)
Commercial A (NF) 20.1 425 1007 Adams et al. (1987)
US. blended NF 85 mm NR 49 162 Djordjevic et al. (1991)
US F Ultra lights NR 8.7 46 Brunnemann and Hoffmann (1991)
US F Lights NR 47 188 Brunnemann and Hoffmann (1991)
US NF NR 49 162 Brunnemann and Hoffmann (1991)
US F NR 75 162 Brunnemann and Hoffmann (1991)
US F Ultra lights NR 17 40 Hoffmann et al. (1994)
US F Lights NR 106 122 Hoffmann et al. (1994)
US F NR 156 209 Hoffmann et al. (1994)
US NF NR 156 278 Hoffmann et al. (1994)
Merit ultima 85 0.7 13 22 Swauger et al. (2002)
Cambridge UL 85 1.3 16 18 Swauger et al. (2002)
Now UL 85 1 17 32 Swauger et al. (2002)
Carlton UL 85 1.1 18 25 Swauger et al. (2002)
GPC UL 100 4.7 46 46 Swauger et al. (2002)
Vantage UL 85 5.1 54 58 Swauger et al. (2002)
Kent LT 85 8.1 62 81 Swauger et al. (2002)
Doral LT 100 M 9 67 53 Swauger et al. (2002)
GPC LT 100 10.7 67 85 Swauger et al. (2002)
Winston UL 85 5.4 69 62 Swauger et al. (2002)
Kool milds 100 11.6 78 79 Swauger et al. (2002)
Marlboro LT 85 10.6 79 113 Swauger et al. (2002)
Capri SSL 100 M 8.6 81 91 Swauger et al. (2002)
Virginia slims UL 100 M 7.2 83 96 Swauger et al. (2002)
Vantage LT 85 8.8 86 66 Swauger et al. (2002)
Marlboro LT 100 11.6 97 142 Swauger et al. (2002)
Cambridge FF 100 14.9 99 111 Swauger et al. (2002)
Monarch FF 85 13.9 102 93 Swauger et al. (2002)
Basic FF 85 M 16.2 102 112 Swauger et al. (2002)
Camel LT Reg 85 10.8 115 76 Swauger et al. (2002)
Pall mall FF 100 12.9 117 181 Swauger et al. (2002)
Marlboro FF 85 16.5 119 175 Swauger et al. (2002)
Marlboro FF 100 14.8 120 191 Swauger et al. (2002)
B&H FF 100 M 15.8 128 168 Swauger et al. (2002)
Salem FF 100 M 17.2 144 168 Swauger et al. (2002)
GPC FF 100 15.2 151 147 Swauger et al. (2002)
Camel FF Reg 85 16.7 188 170 Swauger et al. (2002)
Winston FF 100 15.7 212 129 Swauger et al. (2002)
Commercial J F UL NR 17 40 Brunnemann et al. (1996)
Commercial I F L NR 87 138 Brunnemann et al. (1996)
Commercial H F L NR 106 122 Brunnemann et al. (1996)
Commercial F F M NR 126 151 Brunnemann et al. (1996)
Commercial E F M NR 151 264 Brunnemann et al. (1996)
Commercial D F NR 156 209 Brunnemann et al. (1996)
Commercial A NF NR 156 278 Brunnemann et al. (1996)
Commercial B NF NR 168 274 Brunnemann et al. (1996)
Commercial G F M NR 173 250 Brunnemann et al. (1996)
Commercial C F NR 194 287 Brunnemann et al. (1996)
Control 8.2 75.8 81.3 PM USA (1998)
Control 9.3 79.1 82.9 PM USA (1998)
Control 8.6 81.7 87.6 PM USA (1998)
Control 7.8 81.7 93.9 PM USA (1998)
Control 8.4 92.9 84.9 PM USA (1998)
Control 8.7 90.0 91.0 PM USA (1999)
Salem UL 85 M SP 5 52 64 Swauger et al. (2002)
Merit UL 85 M SP 4.2 55 96 Swauger et al. (2002)
GPC UL 85 SP 5 63 100 Swauger et al. (2002)
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Table 1 (continued)
Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Camel LT 85 SP 10.1 64 100 Swauger et al. (2002)
Merit LT 85 SP 7.8 70 152 Swauger et al. (2002)
Montclair LT 100 SP 10.1 73 173 Swauger et al. (2002)
Merit UL 83 CP 5.1 75 164 Swauger et al. (2002)
Kent Gold LT 85 SP 7.8 81 119 Swauger et al. (2002)
Camel LT 85 CP 9.6 85 133 Swauger et al. (2002)
Newport LT 85 M SP 8.9 86 149 Swauger et al. (2002)
Capri LT 100 CP 8.1 87 112 Swauger et al. (2002)
L&M FF 85 SP 12.9 87 178 Swauger et al. (2002)
Kamel red LT 83 CP 10.5 90 135 Swauger et al. (2002)
Doral FF 85 CP 13.1 90 155 Swauger et al. (2002)
Winston select LT 83 CP 8.4 97 116 Swauger et al. (2002)
Doral FF 85 SP 12.1 97 134 Swauger et al. (2002)
Salem LT 85 M SP 9.8 100 138 Swauger et al. (2002)
Parliament LT 85 SP 8.3 101 185 Swauger et al. (2002)
GPC FF 100 SP 12.7 104 162 Swauger et al. (2002)
Marlboro LT 85 SP 11.1 105 160 Swauger et al. (2002)
Basic LT 100 SP 9.5 110 175 Swauger et al. (2002)
B&H LT 100 M SP 10 111 163 Swauger et al. (2002)
Basic LT 85 M SP 10.4 112 178 Swauger et al. (2002)
Marlboro LT 85 CP 10.3 117 194 Swauger et al. (2002)
Winston FF 85 SP 13.1 119 160 Swauger et al. (2002)
More FF 120 SP 14.8 122 164 Swauger et al. (2002)
Marlboro FF 100 SP 13.8 136 208 Swauger et al. (2002)
GPC FF 83 CP 15.1 137 191 Swauger et al. (2002)
Camel wides FF 80 CP 17 142 185 Swauger et al. (2002)
Richland FF 85 M SP 16.7 143 189 Swauger et al. (2002)
Marlboro LT 85 M SP 9.3 144 225 Swauger et al. (2002)
Marlboro FF 85 SP 15.6 146 246 Swauger et al. (2002)
Newport FF 83 M CP 15.8 147 218 Swauger et al. (2002)
Kool FF 85 M SP 15.1 151 224 Swauger et al. (2002)
Marlboro FF 85 CP 14.2 153 247 Swauger et al. (2002)
Virginia slims FF 100 SP 15.5 154 222 Swauger et al. (2002)
Virginia slims FF 100 M SP 13.4 158 269 Swauger et al. (2002)
Salem FF 100 M SP 17.7 159 259 Swauger et al. (2002)
B&H FF 100 M CP 15.1 168 280 Swauger et al. (2002)
Carlton UL 100 CP 0.4 20 31 Swauger et al. (2002)
Carlton 100 SP 0.9 13 26 Swauger et al. (2002)
Doral UL 100 SP 5 28 46 Swauger et al. (2002)
Pyramid UL 100 SP 5.3 43 55 Swauger et al. (2002)
Salem UL 85 M SP 5 46 54 Swauger et al. (2002)
Doral LT 100 SP 10.5 58 91 Swauger et al. (2002)
Basic UL 100 M CP 5.5 58 97 Swauger et al. (2002)
Winston UL 85 SP 5.2 59 82 Swauger et al. (2002)
Vantage 84 SP 8.4 61 74 Swauger et al. (2002)
Marlboro UL 83 CP 5.8 61 87 Swauger et al. (2002)
Kool LT 84 M SP 7.2 67 79 Swauger et al. (2002)
Salem LT 85 M SP 10.2 73 108 Swauger et al. (2002)
Newport LT 80 M CP 8.8 77 96 Swauger et al. (2002)
Bailey 100 SP 12.7 78 56 Swauger et al. (2002)
Old Gold LT 84 SP 9.2 79 96 Swauger et al. (2002)
Capri 120 M CP 12.3 84 93 Swauger et al. (2002)
Kool FF 85 M SP 15.8 85 110 Swauger et al. (2002)
Camel LT 83 CP 10 86 113 Swauger et al. (2002)
Camel LT 85 SP 11.5 88 117 Swauger et al. (2002)
Marlboro LT 84 SP 11.3 89 123 Swauger et al. (2002)
Winston LT 85 SP 9.3 92 110 Swauger et al. (2002)
GPC 100 SP 13.4 98 146 Swauger et al. (2002)
Basic 99 SP 10.6 100 143 Swauger et al. (2002)
Salem 85 M SP 17.4 102 165 Swauger et al. (2002)
Marlboro LT 84 CP 10.8 103 144 Swauger et al. (2002)
Monarch 100 SP 13.1 105 163 Swauger et al. (2002)
Newport 120 M CP 12 108 160 Swauger et al. (2002)
Winston 84 SP 15.2 110 154 Swauger et al. (2002)
Newport 84 M SP 16.8 111 160 Swauger et al. (2002)
Marlboro FF 100 CP 15 119 177 Swauger et al. (2002)
Marlboro Med 83 CP 12 123 165 Swauger et al. (2002)
Newport 80 M CP 16 124 173 Swauger et al. (2002)
Marlboro 80 CP 14.7 124 186 Swauger et al. (2002)
Camel 83 CP 15.3 131 184 Swauger et al. (2002)
Marlboro King 84 SP 16.5 133 196 Swauger et al. (2002)
Newport 100 M CP 18.7 149 211 Swauger et al. (2002)
USA 85 SP 12.5 185 328 Swauger et al. (2002)
Basic NF 85 SP 28.1 262 343 Swauger et al. (2002)
Merit KS F SP Ultima 1.3 19.2 38 Counts et al. (2005)
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Table 1 (continued)
Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Virginia slims 100 F HP ULt Men 5.1 53.4 78.6 Counts et al. (2005)
Merit KS F SP ULt 4.9 53.9 103.5 Counts et al. (2005)
Marlboro KS F HP ULt Men 5.9 55.1 95.1 Counts et al. (2005)
Marlboro 100 F HP Lt 9.6 87.4 126.9 Counts et al. (2005)
Parliament 100 F SP Lt 11.6 101.3 170.8 Counts et al. (2005)
Marlboro KS F SP 14.2 107.8 157 Counts et al. (2005)
Control 7.5 74.9 105.0 PM USA (2001)
Control 7.5 86.5 99.8 PM USA (2001)
Control 7.7 91.1 104.3 PM USA (2001)
Control 7.3 93.9 127.8 PM USA (2001)
Control 7.4 93.9 94.9 PM USA (2001)
Control 7.2 96.4 106.2 PM USA (2001)
Control 7.5 116.3 138.3 PM USA (2001)
Control 7.4 116.8 152.5 PM USA (2001)
Control 7.7 133.5 150.8 PM USA (2001)
Control 8.6 134.0 166.0 PM USA (2001)
Now KS SP 1.5 23 64 Counts et al. (2006)
Merit ultima 100 HP 2.7 27 55 Counts et al. (2006)
Monarch ULT KS SP 3.6 38 97 Counts et al. (2006)
Liggett select LT 100 SP 9.6 51 88 Counts et al. (2006)
Kent golden lights KS HP 8.1 51 102 Counts et al. (2006)
Merit ULT KS HP 4.9 56 106 Counts et al. (2006)
Virginia slims ULT 100 HP 5.1 58 94 Counts et al. (2006)
Newport LT KS HP 9.5 58 107 Counts et al. (2006)
Kool lights KS SP 8.5 60 96 Counts et al. (2006)
Winston LT KS HP 8.5 61 95 Counts et al. (2006)
Winston Evo LT tin 8.9 61 149 Counts et al. (2006)
Marlboro ULT KS HP 6.2 63 89 Counts et al. (2006)
GPC LT KS HP 9.1 63 96 Counts et al. (2006)
Basic ULT KS HP 5.9 64 88 Counts et al. (2006)
Doral LT KS HP 10.1 71 169 Counts et al. (2006)
Camel LT KS HP 10 74 104 Counts et al. (2006)
Winston KS HP 12.5 75 189 Counts et al. (2006)
Merit LT KS HP 8.2 80 126 Counts et al. (2006)
Doral KS HP 14.3 91 210 Counts et al. (2006)
Basic LT KS HP 10 94 125 Counts et al. (2006)
Marlboro LT KS HP 10.5 96 139 Counts et al. (2006)
Marlboro KS HP 15 104 165 Counts et al. (2006)
Kool KS HP Men 17.1 105 156 Counts et al. (2006)
Salem KS SP Men 16.9 105 234 Counts et al. (2006)
Parliament LT 100 HP 11.4 106 176 Counts et al. (2006)
Basic KS HP 15 124 180 Counts et al. (2006)
Marlboro ultra lights KS HP 5.9 65.0 94.0 PM USA (2002)
Marlboro lights KS HP 9.9 95.0 143.0 PM USA (2002)
Marlboro LS HP 15.0 106.0 170.0 PM USA (2002)
Basic KS SP 14.7 124.0 180.0 PM USA (2002)
Control 8.1 97.1 130.5 PM USA (2002)
Control 7.3 98.2 110.9 PM USA (2002)
Control 8.4 98.7 145.0 PM USA (2002)
Control 7.9 99.0 143.4 PM USA (2002)
Control 7.9 102.0 136.0 PM USA (2002)
Control 7.5 108.8 132.8 PM USA (2002)
Control 7.1 112.3 144.8 PM USA (2002)
Control 7.6 115.8 145.3 PM USA (2002)
Control 7.8 118.0 123.1 PM USA (2002)
Control 8.3 121.0 152.0 PM USA (2002)
Control 7.0 133.5 146.3 PM USA (2002)
Control 7.3 158.8 189.3 PM USA (2002)
Control 7.7 160.0 160.0 PM USA (2002)
Marlboro ultra lights KS HP 6.2 54.0 96.0 PM USA (2003)
Marlboro ultra lights KS HP 6.4 62.0 110.0 PM USA (2003)
Marlboro lights KS HP 10.6 85.0 138.0 PM USA (2003)
Marlboro lights KS HP 10.8 92.0 148.0 PM USA (2003)
Marlboro blend 27 HP 12.2 93.0 140.0 PM USA (2003)
Marlboro blend 27 HP 12.3 108.0 150.0 PM USA (2003)
Basic KS SP 14.9 127.0 169.0 PM USA (2003)
Basic KS SP 15.5 128.0 178.0 PM USA (2003)
Control 8.4 92.3 167.4 PM USA (2003)
Control 7.8 105.9 152.6 PM USA (2003)
Control 7.2 110.0 157.0 PM USA (2003)
Control 8.1 112.0 147.0 PM USA (2003)
Control 7.3 112.0 169.8 PM USA (2003)
Control 7.6 115.0 155.0 PM USA (2003)
Control 7.9 117.0 165.0 PM USA (2003)
Control 7.5 118.0 171.0 PM USA (2003)
(continued on next page)
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Table 1 (continued)
Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Control 7.6 124.0 165.0 PM USA (2003)
Control 7.7 125.3 157.0 PM USA (2003)
Control 8.3 126.0 177.0 PM USA (2003)
Control 7.7 126.8 164.2 PM USA (2003)
Marlboro ultra lights KS HP 6.0 49.0 92.0 PM USA (2004)
Marlboro ultra lights KS HP 6.1 51.0 93.0 PM USA (2004)
Marlboro ultra lights KS HP 6.2 53.0 93.0 PM USA (2004)
Marlboro ultra lights KS HP 6.0 58.0 99.0 PM USA (2004)
Marlboro lights KS HP 10.6 74.0 132.0 PM USA (2004)
Marlboro lights KS HP 10.6 77.0 137.0 PM USA (2004)
Marlboro lights KS HP 10.5 77.0 137.0 PM USA (2004)
Marlboro lights KS HP 10.6 85.0 136.0 PM USA (2004)
Marlboro blend 27 HP 12.6 89.0 131.0 PM USA (2004)
Marlboro blend 27 HP 12.7 91.0 139.0 PM USA (2004)
Marlboro LS HP 15.3 94.0 176.0 PM USA (2004)
Marlboro LS HP 15.5 95.0 177.0 PM USA (2004)
Marlboro blend 27 HP 12.4 100.0 136.0 PM USA (2004)
Marlboro blend 27 HP 13.1 100.0 143.0 PM USA (2004)
Basic KS SP 15.3 116.0 156.0 PM USA (2004)
Basic KS SP 15.5 118.0 168.0 PM USA (2004)
Basic KS SP 15.3 120.0 161.0 PM USA (2004)
Basic KS SP 15.0 130.0 175.0 PM USA (2004)
Control 8.0 77.6 116.0 PM USA (2004)
Control 7.6 82.0 116.0 PM USA (2004)
Control 8.5 87.4 122.0 PM USA (2004)
Control 8.7 87.8 124.0 PM USA (2004)
Control 8.2 89.4 121.0 PM USA (2004)
Control 7.7 89.5 133.0 PM USA (2004)
Control 7.9 96.4 146.0 PM USA (2004)
Control 8.1 102.0 128.0 PM USA (2004)
Control 6.7 110.0 132.0 PM USA (2004)
Control 7.0 122.0 143.0 PM USA (2004)
Control 8.3 122.0 152.0 PM USA (2004)
Merit ultima 1.63 16.4 42 Roemer et al. (2004)
Virginia slims superslim 4.88 51.2 66 Roemer et al. (2004)
Virginia slims ultra lights 5.47 56.4 83 Roemer et al. (2004)
Marlboro lights 10 94.2 137 Roemer et al. (2004)
Benson & hedges 100 lights 11.23 99.2 139 Roemer et al. (2004)
Marlboro 14.51 128.1 196 Roemer et al. (2004)
Parliament lights 100 11.8 131.2 196 Roemer et al. (2004)
Basic 23.05 223.5 270 Roemer et al. (2004)
Marlboro ultra lights KS HP 6.2 43.0 83.0 PM USA (2005)
Marlboro ultra lights KS HP 6.1 43.0 87.0 PM USA (2005)
Marlboro ultra lights KS HP 5.9 46.0 85.0 PM USA (2005)
Marlboro ultra lights KS HP 6.1 48.0 89.0 PM USA (2005)
Marlboro lights KS HP 11.3 67.0 132.0 PM USA (2005)
Marlboro lights KS HP 11.2 68.0 126.0 PM USA (2005)
Marlboro lights KS HP 10.9 70.0 123.0 PM USA (2005)
Marlboro lights KS HP 11.0 73.0 131.0 PM USA (2005)
Marlboro Blend 27 HP 12.4 78.0 134.0 PM USA (2005)
Marlboro LS HP 15.2 81.0 161.0 PM USA (2005)
Marlboro Blend 27 HP 12.4 82.0 127.0 PM USA (2005)
Marlboro LS HP 15.4 83.0 160.0 PM USA (2005)
Marlboro Blend 27 HP 13.3 84.0 132.0 PM USA, 2005
Marlboro LS HP 14.9 85.0 155.0 PM USA (2005)
Marlboro Blend 27 HP 12.0 89.0 139.0 PM USA (2005)
Marlboro LS HP 15.2 92.0 165.0 PM USA (2005)
Basic KS SP 15.7 97.0 139.0 PM USA (2005)
Basic KS SP 14.8 103.0 141.0 PM USA (2005)
Basic KS SP 15.3 104.0 134.0 PM USA (2005)
Basic KS SP 15.7 118.0 155.0 PM USA (2005)
Control 7.4 72.5 112.0 PM USA (2005)
Control 8.5 74.7 125.4 PM USA (2005)
Control 7.9 75.8 137.0 PM USA (2005)
Control 7.8 78.7 146.0 PM USA (2005)
Control 8.0 83.4 118.0 PM USA (2005)
Control 8.5 85.0 155.2 PM USA (2005)
Control 8.3 89.2 140.2 PM USA (2005)
Control 8.1 89.7 145.2 PM USA (2005)
Marlboro ultra lights KS HP 5.6 45.0 80.0 PM USA (2006)
Marlboro ultra lights KS HP 5.6 46.0 81.0 PM USA (2006)
Marlboro lights KS HP 10.7 62.0 120.0 PM USA (2006)
Marlboro lights KS HP 10.7 72.0 124.0 PM USA (2006)
Marlboro blend 27 HP 12.0 75.0 124.0 PM USA (2006)
Marlboro LS HP 14.6 78.0 151.0 PM USA (2006)
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Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Marlboro blend 27 HP 12.0 84.0 124.0 PM USA (2006)
Marlboro LS HP 14.6 85.0 149.0 PM USA (2006)
Basic KS SP 14.6 91.0 133.0 PM USA (2006)
Basic KS SP 14.6 92.0 137.0 PM USA (2006)
Control 7.9 69.7 108.0 PM USA (2006)
Control 8.5 76.8 122.0 PM USA (2006)
Control 9.0 81.6 152.2 PM USA (2006)
Control 8.0 91.7 133.9 PM USA (2006)
Control 8.1 77.6 108.0 PM USA (2007)
Marlboro ultra lights 5.77 49 79 Patskan et al. (2008)
Marlboro lights 9.58 82 122 Patskan et al. (2008)
Marlboro full ﬂavor 13.5 104 151 Patskan et al. (2008)
Natural American spirit 19.3 18.7 18.5 PM USA (2010)
Marlboro 72s silver pack 6.2 35.8 82.2 PM USA (2010)
Marlboro silver pack KS 6.7 36.6 59.5 PM USA (2010)
Camel blue KS 10.4 38.8 47.5 PM USA (2010)
Marlboro virginia blend KS 11.7 41.3 22.9 PM USA (2010)
Merit gold pack KS 7.4 45.0 70.2 PM USA (2010)
Newport menthol box 15.5 47.0 125.1 PM USA (2010)
Kool menthol ﬁlter KS box 15.8 48.2 69.2 PM USA (2010)
Marlboro menthol gold pack KS 10.7 49.7 71.2 PM USA (2010)
Marlboro gold pack KS 11.1 53.5 81.2 PM USA (2010)
Pall mall red 100 14.6 66.8 87.3 PM USA (2010)
Basic box KS 14.7 89.7 125.0 PM USA (2010)
Marlboro virginia blend NR 25.5 19.5 Stepanov et al. (2012)
Camel No. 9 menthol NR 43.4 75.2 Stepanov et al. (2012)
Camel No. 9 NR 44.4 102.8 Stepanov et al. (2012)
Camel silver NR 45.6 100.3 Stepanov et al. (2012)
Camel crush NR 48.1 96.9 Stepanov et al. (2012)
Kool ﬁlter kings NR 63 135.8 Stepanov et al. (2012)
Newport menthol NR 65.6 151.8 Stepanov et al. (2012)
Camel full ﬂavor NR 67.5 120.2 Stepanov et al. (2012)
Pall mall full ﬂavor NR 72.8 114.3 Stepanov et al. (2012)
Marlboro special blend NR 77.3 141.6 Stepanov et al. (2012)
Winston full ﬂavor NR 78.5 172.8 Stepanov et al. (2012)
Marlboro smooth menthol NR 86.4 164.2 Stepanov et al. (2012)
Marlboro full ﬂavor NR 90.3 171 Stepanov et al. (2012)
Marlboro blend No. 27 NR 91.2 145.2 Stepanov et al. (2012)
Doral full ﬂavor NR 100.4 225.9 Stepanov et al. (2012)
Marlboro blend No. 54 NR 133.7 232.1 Stepanov et al. (2012)
Basic full ﬂavor NR 146.1 207.1 Stepanov et al. (2012)
Marlboro virginia blend KS 11.7 19.6 18.9 PM USA (2011)
Natural American spirit (Blue Pack) 15.1 22.2 18.6 PM USA (2011)
Marlboro virginia blend KS 11.4 22.2 20.9 PM USA (2011)
Marlboro virginia blend KS 10.8 25.1 26.2 PM USA (2011)
Natural American spirit (Blue Pack) 19.1 25.6 20.4 PM USA (2011)
Natural American spirit 17.9 31.5 30.0 PM USA (2011)
Marlboro 72s silver pack 6.3 33.3 72.93 PM USA (2011)
Marlboro 72s silver pack 6.9 35.6 77.3 PM USA (2011)
Marlboro Silver Pack KS 6.0 36.0 56.5 PM USA (2011)
Marlboro 72s silver pack 5.8 36.1 78.9 PM USA (2011)
Marlboro virginia blend KS 11.6 37.3 32.0 PM USA (2011)
Marlboro silver pack KS 6.4 39.1 64.9 PM USA (2011)
Natural American spirit (Blue Pack) 18.6 39.6 23.7 PM USA (2011)
Marlboro silver pack KS 6.3 40.1 62.3 PM USA (2011)
Marlboro 72s silver pack 6.5 40.1 76.2 PM USA (2011)
Marlboro silver pack KS 5.9 42.8 67.4 PM USA (2011)
Camel Blue KS 10.4 43.3 59.2 PM USA (2011)
Newport Menthol Box 14.8 44.7 97.5 PM USA (2011)
Merit Gold Pack KS 7.3 45.0 82.6 PM USA (2011)
Camel Blue KS 10.7 45.0 71.0 PM USA (2011)
Newport Menthol Box 14.0 47.4 98.5 PM USA (2011)
Merit Gold Pack KS 7.5 47.8 73.6 PM USA (2011)
Camel Blue KS 11.2 48.6 64.1 PM USA (2011)
Merit Gold Pack KS 7.1 49.6 72.4 PM USA (2011)
Newport Menthol Box 14.6 53.8 130.0 PM USA (2011)
Camel Blue KS 12.0 54.0 85.0 PM USA (2011)
Merit Gold Pack KS 7.3 55.1 86.2 PM USA (2011)
Marlboro Gold Pack KS 10.0 57.4 86.8 PM USA (2011)
Newport Menthol Box 14.4 57.4 127.0 PM USA (2011)
Marlboro Menthol Gold Pack KS 9.5 57.6 70.7 PM USA (2011)
Marlboro Gold Pack KS 10.3 58.2 88 PM USA (2011)
Marlboro Menthol Gold Pack KS 9.4 59.1 77.3 PM USA (2011)
Marlboro Menthol Gold Pack KS 9.0 60.4 83.5 PM USA (2011)
Kool Menthol Filter KS Box 15.1 63.5 83.4 PM USA (2011)
(continued on next page)
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Table 1 (continued)
Cigarettea Tar (mg/cigarette) NNK (ng/cigarette) NNN (ng/cigarette) Source
Marlboro Gold Pack KS 10.9 63.6 96.3 PM USA (2011)
Marlboro Menthol Gold Pack KS 9.1 66.4 95.4 PM USA (2011)
Marlboro Gold Pack KS 10.4 67.7 99.7 PM USA (2011)
Kool Menthol Filter KS Box 15.6 69.6 113.0 PM USA (2011)
Pall Mall Red 13.1 70.0 103.5 PM USA (2011)
Pall Mall Red KS 14.6 70.6 76.2 PM USA (2011)
Kool Menthol Filter KS Box 16.3 73.7 87.4 PM USA (2011)
Basic Box KS 11.4 73.8 108.0 PM USA (2011)
Pall Mall Red 100 13.3 79.3 103.0 PM USA (2011)
Kool Menthol Filter KS Box 15.4 79.4 101.0 PM USA (2011)
Doral Red 100’s 13.3 83.4 95.4 PM USA (2011)
Pall Mall Red KS 13.8 85.5 82.9 PM USA (2011)
Basic Box KS 14.2 85.6 126.0 PM USA (2011)
Basic Box KS 14.1 86.8 112 PM USA (2011)
Basic Box KS 14.7 98.5 139.7 PM USA (2011)
Marlboro Virginia Blend KS 11.4 19.6 18.4 PM USA (2012)
Natural American Spirit (Blue Pack) 18.6 25.1 23.3 PM USA (2012)
Marlboro 72s silver pack 5.6 36.1 64.7 PM USA (2012)
Marlboro silver pack KS 6.3 38.2 55.9 PM USA (2012)
Camel blue KS 10.6 48.5 67.1 PM USA (2012)
Merit gold pack KS 6.2 48.9 67.8 PM USA (2012)
Newport menthol box 14.9 53.1 88.2 PM USA (2012)
Marlboro menthol gold pack KS 10.5 63.0 78.2 PM USA (2012)
Marlboro gold pack KS 10.6 63.9 88.2 PM USA (2012)
Kool menthol ﬁlter KS Box 15.2 66.1 91.3 PM USA (2012)
Pall mall red KS 13.1 69.1 81.5 PM USA (2012)
Basic box KS 14.8 85.7 103.4 PM USA (2012)
NNK = 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN = N-nitrosonornicotine; NR = not reported; PM USA = Philip Morris USA.
a See referenced sources for cigarette sample descriptions. For PM USA data, abbreviations are: HP = hard pack; KS = king size; LS = long size; SP = soft pack.
Fig. 1. Scatter plot of 35 years of data as the sum of NNK plus NNN in mainstream
smoke, expressed as ng/cigarette.
Fig. 2. Scatter plot of 35 years of data as the sum of NNK plus NNN in mainstream
smoke, expressed as ng/mg tar.
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these data is presented in Fig. 3.
These data show a scatter of a wide range of values for NNK per
cigarette from 1978–1995. Values for smoke NNK levels presented
in the Hoffmann papers as evidence of an increasing trend in TSNA
levels fall within the overall range of scatter plot values. NNK per
cigarette trended down from 1978–1995 (R = 0.57) and the trend
was statistically signiﬁcant (p < 0.00001). This result is in contrast
with the conclusions of Hoffmann and Hoffmann (1997).3.3. About analytical methods for measuring MS smoke TSNA levels
A variety of methods have been used to quantify MS smoke
TSNA levels over the past three decades. Prior to the mid-1990s,
the methods were essentially research methods with little
published documentation related to method validation andstandardization across various laboratories. Figs. 1 and 2 show that
TSNA levels in cigarette smoke within a given year are variable,
even when normalized by tar levels. Reported TSNA levels ap-
peared to be higher and more variable prior to the mid-1990s
compared with levels reported in post-2000 studies. With the
information available, it is not possible to determine the relative
contributions of analytical variation and other factors to total
variability.
To address the issue of uncertain validation or standardization
of methods across various laboratories for smoke TSNA levels over
35 years, we assessed data generated by PM USA and its contracted
laboratories over the past 10 years. We selected this time period
for several reasons. Analytical methods used in determining TSNAs
in MS cigarette smoke have been harmonized among these labora-
tories starting in the late 1990s. PM USA and its contracted labora-
tories have undergone laboratory quality systems accreditation,
such as ISO 17025, and have participated in collaborative studies
Fig. 3. Scatter plot of data reported for the years 1979–1995 for NNK in mainstream
smoke, expressed as ng/cigarette.
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TSNAs. These include CORESTAMethods No. 63 and No. 75 (CORES-
TA, 2005, 2012). In addition, it is routine practice among these
laboratories to measure MS smoke TSNA levels for reference and
monitor cigarettes, which allows for method quality control and
comparison across laboratories.
Except for data from Stepanov et al. (2012), all of the data pre-
sented from 2002–2012 were from PM USA afﬁliated and
contracted laboratories. Because Stepanov et al. (2012) did not
present tar levels in their report, these data cannot be compared
with other TSNA data expressed on a per mg tar basis. Therefore,
all of the data for the years 2002–2012 presented in Fig. 2 were
from PM USA afﬁliated laboratories. This data set includes 219 cig-
arette samples of various designs and from various manufacturers.
Finally, implementation of various TSNA reduction efforts by
the tobacco industry and agricultural community began around
the year 2000. If such efforts resulted in reductions in MS smoke
TSNA levels, they should be detected in this time period.
Fig. 2 suggests an overall downward trend of MS smoke TSNA
levels over the past decade. For the period 2002–2012,
(NNK + NNN)/tar trended down over time (R = 0.70) and the
trend was statistically signiﬁcant (p < 0.00001).4. Discussion
The US Surgeon General and others state that the role of speciﬁc
smoke constituents in smoking related disease is currently not
known (Burns et al., 2008; USDHHS, 2010). Likewise, it is not
known whether reduction of the levels of TSNAs in MS cigarette
smoke would result in a reduction in the risk of smoking-related
disease.
For more than a decade, PM USA along with other tobacco com-
panies and the agricultural community have actively researched
the fundamental science related to TSNA formation, TSNA levels
in tobacco and tobacco smoke, and methods to reduce these levels.
One outcome of this research was the retroﬁtting of commercial
curing barns, in 2000, from direct-ﬁred to heat-exchanger systems.
Prior to that year, Virginia tobacco was cured in barns equipped
with direct-ﬁred propane or liquid petroleum gas burners. In
1999, it was recognized that substantial reductions in TSNAs
occurred in ﬂue-cured tobacco that was cured in barns equipped
with heat-exchangers as compared with tobacco that was cured
using the direct-ﬁre method (Nestor et al., 2003; Peele et al.,
1999). An industry-wide retroﬁtting of US commercial curing barns
from direct-ﬁred to the heat-exchanger system started in 2000with farmers’ expenses partially reimbursed by an industry-sup-
ported cost-share program (Reed, 2009). A similar effort was
undertaken in Canada (Rickert et al., 2008). Because the effect of
heat exchangers in reducing TSNAs is effective only for Virginia
tobaccos, its impact in reducing TSNA levels in cigarette smoke is
dependent on the amount of Virginia tobacco in the ﬁnal tobacco
blend. Additional measures have also been implemented to further
reduce TSNA levels in burley tobacco. For example, tobacco seed
screening for low conversion of nicotine to nornicotine, a precursor
to NNN formation in burley tobacco, is now widely implemented
(Jack et al., 2007). Additionally, PM USA requires that US tobacco
growers adhere to other production practices designed to
minimize TSNA for Virginia and burley tobaccos similar to those
deﬁned by tobacco production guides issued by several agricul-
tural authorities (North Carolina State University Cooperative
Extension, 2011; University of Tennessee Institute of Agriculture
and University of Kentucky College of Agriculture, 2011; Virginia
Cooperative Extension and Virginia Polytechnic Institute and
Virginia State University, 2011).
Evidence suggests that efforts by the tobacco industry and agri-
cultural community to reduce TSNA levels in cigarette tobacco
have been making progress. Counts measured tobacco ﬁller TSNA
levels in 26 US. commercial cigarette brands that were sampled
in 2002 (Counts et al., 2006). The average level of NNK plus NNN
in tobacco ﬁller from these 26 brands was 4.4 lg/g. Morton and
Laffoon measured tobacco ﬁller TSNA levels in 23 US. commercial
cigarette brands that were sampled in 2004–2005 (Morton and
Laffoon, 2008). The average level of NNK plus NNN in tobacco ﬁller
from these 23 brands was 3.9 lg/g. Stepanov measured tobacco ﬁl-
ler TSNA levels in 17 US. commercial cigarette brands that were
sampled in 2010 (Stepanov et al., 2012). The average level of
NNK plus NNN (adjusted for moisture) of the 17 commercial
cigarette samples measured by Stepanov et al. was 2.9 lg/g. This
represents a reduction in tobacco ﬁller NNK plus NNN of 35% and
27% from 2002 to 2010 and 2004–2005 to 2010, respectively. These
trends are consistent with the trends in smoke NNK plus NNN
reported in our work.
In a presentation to the 2012 CORESTA Congress, Gunduz et al.
reported that between 2000 and 2010, the average NNN content of
tobacco ﬁller from over 250 international cigarette brands was
reduced by approximately 30% while the average NNK content
was reduced by approximately 50%. These ﬁndings are consistent
with the reductions in tobacco ﬁller NNK plus NNN in US. commer-
cial cigarettes indicated by comparing the results reported by
Counts et al., Morton and Laffoon, and Stepanov et al. noted above.
Gunduz et al. also reported substantial reductions in NNK and NNN
levels in Virginia and burley tobacco lots produced in the US from
1999 to 2011 (Gunduz et al., 2012).
Contrary to the reductions noted above, Stepanov et al. reported
that there has been no change in TSNA levels in cigarette tobacco
ﬁller over the past 30 years (Stepanov et al., 2012). The lack of
agreement between the previously noted ﬁndings and conclusions
of Stepanov et al. may be due to the relatively small number of
tobacco ﬁller samples used by Stepanov et al. to infer a trend in
TSNA levels over three decades. The investigators relied on one
sample from an unidentiﬁed cigarette in 1979, ﬁve samples from
unidentiﬁed cigarettes in 1995, and 17 samples from identiﬁed cig-
arettes in 2010.
Based on the analysis presented here, TSNA levels in cigarette
smoke appear to be on a downward trend and have been for a num-
ber of years. This is evident in all scatter plots, but it is particularly
evident in plots of TSNA levels that are normalized for tar levels.
Likewise, this trend is particularly evident in cigarettes analyzed
within the past 10 years. This latter observation is consistent with
the timing of implementation of various efforts by the tobacco
industry and agricultural community to reduce TSNAs in tobacco.
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cigarette smoke have increased over time. Therefore, the conclu-
sion by Hoffmann and Hoffmann (1997) that NNK levels have in-
creased in smoke of commercially available cigarettes from
1979–1995 is not supported by data published during that time
period. Likewise, our analysis is contrary to the contention by
Stepanov et al. (2012) that there is no apparent signiﬁcant reduc-
tion in smoke TSNA levels over the past decade.
The analyses discussed here should be considered in light of
several limitations. The ideal study to address the question of
trends in TSNA levels in MS smoke of cigarettes over time would
be a longitudinal study spanning many years, employing a single
cigarette design manufactured over many tobacco crop years,
and using the same validated and standardized methods to analyze
all samples over the course of the study. Ideally, such a study
would include a reference cigarette that was manufactured at a
single point in time and tested on multiple occasions over the
course of the study as a test of stability of analytical results over
time. To our knowledge, no such study has ever been conducted.
The data that are available come from a variety of sources
published over a period of 35 years. These data comprise a wide
range of cigarette designs from multiple manufacturers analyzed
by various laboratories using a variety of analytical methods which
were unlikely to have been standardized across laboratories. Data
on variability of the measurements such as standard deviation
are not available for some of the data set. With the information
available, it is not possible to determine the relative contributions
of analytical variation and other factors to total variability.
The samples selected for testing by various investigators may or
may not have been representative of the range of all products in
the market at a given point in time. Many of the samples were de-
scribed only as commercial ﬁlter or non-ﬁlter cigarettes. Despite
these limitations, the data set that does exist is relatively large
(several hundred cigarette samples) and includes a wide variety
of cigarette designs and market leaders. It is therefore reasonable
to assume that the data can inform some general inferences about
time trends of TSNA levels in cigarette smoke, particularly within
time frames narrower than 35 years.
Smoke TSNA data presented in this manuscript was generated
by machines smoking cigarettes under FTC/ISO smoking condi-
tions. It is unlikely that smoke TSNA data generated under more in-
tense smoking conditions, such as the Health Canada regimen,
would result in a different outcome than the one reported in the
present work. While a more intense smoking regimen would result
in different absolute levels of smoke TSNA, there is no evidence
that such a difference would change over time in a way that would
reverse a trend identiﬁed by FTC/ISO smoking regimens. In their
presentation to the 2012 CORESTA Congress, Gunduz et al. re-
ported that between 2000 and 2010 the average NNK and NNN lev-
els in mainstream cigarette smoke were reduced by approximately
13% and 23% respectively in a study testing a large number of inter-
national cigarette brands. This is consistent with our ﬁndings de-
spite the fact that smoke TSNA data reported by Gunduz et al.
were obtained using Health Canada smoking conditions.
In conclusion, this review of data collected over the past
35 years does not support the suggestion that TSNA levels in MS
smoke of US commercial cigarettes have increased over time. On
the contrary, the general impression of this data set is that TSNA
levels in MS cigarette smoke appear to be generally decreasing.
The statistical analyses are consistent with this impression. This
trend is particularly evident over the past 10 years. The apparent
downward trend in TSNA levels in MS smoke of US commercial cig-
arettes is consistent with efforts implemented by the tobacco
industry and the agricultural community to reduce levels of TSNAs
in tobacco and cigarette smoke.Conﬂict of interest
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